Periostin Expression is Altered in Aortic Valves in Smad6 Mutant Mice

Area of Science:

• Developmental Biology
• Molecular Biology
• Cardiovascular Biology

Background:

• Smad6 inhibits Bone Morphogenetic Protein (BMP) signaling.
• Periostin, an extracellular matrix (ECM) protein, is crucial for cardiac valve development and disease.
• Smad6 mutations offer a model to study BMP signaling's role in vivo.

Purpose of the Study:

• Investigate periostin and ECM protein expression in Smad6-mutant mice.
• Focus on outflow tract (OT) and adult valve development.
• Understand the role of BMP signaling in valve interstitial cell differentiation.

Main Methods:

• Immunohistochemistry and immunointensity analysis in Smad6-/- neonatal mouse hearts.
• Localization of periostin during embryonic outflow tract development.
• Assessment of periostin, versican, and hyaluronan deposition.

Main Results:

• Periostin expression was significantly reduced in aortic valves of Smad6-/- neonatal hearts.
• Versican expression was also significantly reduced in Smad6-/- aortic valves.
• Hyaluronan deposition was not significantly altered; effects were less pronounced in AV valves.

Conclusions:

• Smad6 deficiency leads to reduced periostin and versican in aortic valves.
• Cell lineage and regulatory molecule responses influence valve interstitial cell development.
• BMP signaling, modulated by Smad6, is critical for ECM protein expression in aortic valves.